Dubé Valérie, Macdonald Denis, Allingham-Hawkins Diane J, Kamel-Reid Suzanne, Colgan Terence J
Department of Pathology, Mount Sinai Hospital, Toronto, Ontario, Canada.
Int J Gynecol Pathol. 2007 Jul;26(3):271-7. doi: 10.1097/01.pgp.0000236945.74711.ef.
Three cases of histologically proven endometrial carcinoma (EmCa) demonstrated no residual carcinoma or biopsy site on the subsequent hysterectomy specimen. The shared identity of both endometrial biopsy and hysterectomy specimen was proven, and specimen misidentification was excluded in all 3 cases through successful DNA profiling. Just as vanishing cancer in prostatic carcinoma has recently been defined and accepted, it is suggested that vanishing EmCa can also be defined using specific pathological and clinical criteria. DNA profiling may serve to confirm the diagnosis. Vanishing EmCa is only a small subset within hysterectomy specimens that show no EmCa after a histological diagnosis of EmCa. The concept of vanishing EmCa may be useful in both clinical and medicolegal practice.
三例经组织学证实的子宫内膜癌(EmCa)患者在随后的子宫切除标本中未发现残留癌或活检部位。经证实,子宫内膜活检和子宫切除标本的一致性良好,通过成功的DNA分型排除了所有3例标本误认的情况。正如最近前列腺癌中的消失癌已被定义并得到认可一样,有人提出消失性EmCa也可以使用特定的病理和临床标准来定义。DNA分型可能有助于确诊。消失性EmCa只是子宫切除标本中的一个小亚组,这些标本在组织学诊断为EmCa后未显示EmCa。消失性EmCa的概念在临床和法医学实践中可能都有用。